Millennium Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Millennium Management’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,260	Closed	-$87K	–	6791
2023 Q2	$87K	Sell	12,260 -27,110	-69%	-$188K	﹤0.01%	5357
2023 Q1	$293K	Buy	+39,370	New	+$331K	﹤0.01%	4922
2021 Q3	–	Sell	-6,190	Closed	-$859K	–	7423
2021 Q2	$859K	Hold	6,190	–	–	﹤0.01%	4801
2021 Q1	$1.29M	Buy	+6,190	New	+$1.24M	﹤0.01%	3959

Millennium Management's HARP Position: Q1 2024 in Review

Millennium Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 25,465 shares — an estimated $290K sold.

Millennium Management first reported a position in HARP in Q1 2019 and held it in 18 quarters. The position peaked at $4.76M in Q3 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Millennium Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 25,465 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $290K.
Millennium Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 18 quarters.
Millennium Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $4.76M in Q3 2021.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.